Targeting of the AKT/m-TOR Pathway: Biomarkers of Resistance to Cancer Therapy——
AKT/m-TOR Pathway and Resistance to Cancer Therapy

by Liudmila V SPIRINA, Irina V KONDAKOVA, Natalia V TARASENKO, Elena M SLONIMSKAYA, Evgeny A USYNIN, Alexey K GORBUNOV, Zahar A YURMAZOV, Svetlana Yu CHIGEVSKAYA
Published 2018-01-01

Amplifications of Stemness Gene Loci—New Markers for the Determination of the Need for Neoadjuvant Chemotherapy for Patients with Breast Cancer. A Prospective Study

by Nikolai V. Litviakov, Marina K. Ibragimova, Matvey M. Tsyganov, Polina V. Kazantseva, Artem V. Doroshenko, Eugeniy Yu. Garbukov, Irina G. Frolova, Elena M. Slonimskaya
Published 2021-05-01

Proteasome functioning in breast cancer: connection with clinical-pathological factors.

by Elena E Shashova, Yulia V Lyupina, Svetlana A Glushchenko, Elena M Slonimskaya, Olga V Savenkova, Alexey M Kulikov, Nikolay G Gornostaev, Irina V Kondakova, Natalia P Sharova
Published 2014-01-01

Heterogeneity of Circulating Tumor Cells in Neoadjuvant Chemotherapy of Breast Cancer

by Evgeniya V. Kaigorodova, Olga E. Savelieva, Liubov A. Tashireva, Natalia A. Tarabanovskaya, Elena I. Simolina, Evgeny V. Denisov, Elena M. Slonimskaya, Evgeny L. Choynzonov, Vladimir M. Perelmuter
Published 2018-03-01